Lecture Objectives

• Discuss the latest epidemiology of HCV in the US, the importance of universal screening and highlight data on HCV treatment in special populations including pregnant women and pediatric patients. 

• Explain the mechanisms of novel anti-HBV therapies and their impact on hepatic biomarkers, viral activity, HBV gene expression.

• Explore the diagnostic algorithm and new therapy for hepatitis D 

About Dr. Jesudian
Dr. Jesudian is a Transplant Hepatologist in the Center for Liver Disease and Transplantation of NewYork-Presbyterian Hospital/Weill Cornell Medicine. He is the Director of Inpatient Liver Services at NYPH/Weill Cornell and also serves as a member of the Department of Medicine Quality Improvement Patient Safety Committee. His clinical research focuses on the areas of quality improvement in cirrhosis management and complications of portal hypertension.